Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jul 3;83(3):307–310. doi: 10.1054/bjoc.2000.1247

Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions

S Andersson 1, M Alemi 2, E Rylander 1, A Strand 3, B Larsson 1, J Sällström 2, E Wilander 2
PMCID: PMC2374570  PMID: 10917543

Abstract

A previous Swedish study revealed that both prototype and variant HPV16 E6 oncoprotein, occur in about equal numbers in high-grade cervical intraepithelial neoplasia (HCIN), whereas variant HPV16 predominates in invasive cervical squamous carcinoma. Most of the malignant HPV16 variants contain a common mutation, L83V, in the E6 oncoprotein. In the present investigation, 28 HPV16 positive, invasive cervical adenocarcinomas were collected from a total number of 131 adenocarcinomas. These HPV16-positive cases were evaluated with analysis of the E6 gene, using a recently described PCR-SSCP method for identification of the specific mutation (L83V) in the E6 gene. The results obtained were correlated to findings in 103 preinvasive, HCIN, and 31 invasive cervical squamous carcinomas also infected with HPV16. The HPV16 E6 variant L83V was present in 40% of the HCIN lesions, in 54% of the invasive adenocarcinomas, in comparison to 81% of the invasive squamous carcinomas. The difference between HCIN and squamous carcinomas was statistically significant, P< 0.001, whereas the difference between HCIN and invasive adenocarcinomas was not statistically significant, P = 0.604. Prototype HPV16 and its E6 variant L83V are both prevalent in preinvasive and invasive cervical lesions in Swedish women. However, the obvious predominance of HPV16 variant in squamous carcinomas was not seen in adenocarcinomas. A single amino-acid shift in the HPV16 E6 gene appears to result in a different transforming potential in squamous and glandular cervical lesions. © 2000 Cancer Research Campaign

Keywords: HPV16; E6 gene, polymorphism; cervical adenocarcinomas

Full Text

The Full Text of this article is available as a PDF (86.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alemi M., Andersson S., Sällström J., Wilander E. Rapid test for identification of a human papillomavirus 16 E6 L83V variant. Diagn Mol Pathol. 1999 Jun;8(2):97–100. doi: 10.1097/00019606-199906000-00006. [DOI] [PubMed] [Google Scholar]
  2. Barbosa M. S., Lowy D. R., Schiller J. T. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J Virol. 1989 Mar;63(3):1404–1407. doi: 10.1128/jvi.63.3.1404-1407.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergström R., Sparén P., Adami H. O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999 Sep;81(1):159–166. doi: 10.1038/sj.bjc.6690666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  5. Dargent D. Cancer de la vulve. Rev Prat. 1997 Oct 1;47(15):1684–1689. [PubMed] [Google Scholar]
  6. Gustafsson L., Adami H. O. Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer. 1989 Jul;60(1):132–141. doi: 10.1038/bjc.1989.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hording U., Daugaard S., Junge J., Lundvall F. Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol. 1996 Jul;15(3):230–234. doi: 10.1097/00004347-199607000-00007. [DOI] [PubMed] [Google Scholar]
  8. Kurman R. J., Schiffman M. H., Lancaster W. D., Reid R., Jenson A. B., Temple G. F., Lorincz A. T. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol. 1988 Aug;159(2):293–296. doi: 10.1016/s0002-9378(88)80070-x. [DOI] [PubMed] [Google Scholar]
  9. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996 Oct 21;69(5):364–368. doi: 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  10. Lungu O., Wright T. C., Jr, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes. 1992 Apr;6(2):145–152. doi: 10.1016/0890-8508(92)90059-7. [DOI] [PubMed] [Google Scholar]
  11. Moreno V., Muñoz N., Bosch F. X., de Sanjosé S., Gonzalez L. C., Tafur L., Gili M., Izarzugaza I., Navarro C., Vergara A. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):459–467. [PubMed] [Google Scholar]
  12. Nuovo G. J., Delvenne P., MacConnell P., Chalas E., Neto C., Mann W. J. Correlation of histology and detection of human papillomavirus DNA in vulvar cancers. Gynecol Oncol. 1991 Dec;43(3):275–280. doi: 10.1016/0090-8258(91)90035-4. [DOI] [PubMed] [Google Scholar]
  13. Nuovo G. J., Walsh L. L., Gentile J. L., Blanco J. S., Koulos J., Heimann A. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions. Am J Clin Pathol. 1991 Oct;96(4):544–548. doi: 10.1093/ajcp/96.4.544. [DOI] [PubMed] [Google Scholar]
  14. Ostör A. G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993 Apr;12(2):186–192. [PubMed] [Google Scholar]
  15. Saiki R. K., Chang C. A., Levenson C. H., Warren T. C., Boehm C. D., Kazazian H. H., Jr, Erlich H. A. Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med. 1988 Sep 1;319(9):537–541. doi: 10.1056/NEJM198809013190903. [DOI] [PubMed] [Google Scholar]
  16. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  17. Zehbe I., Sällström J. F., Evander M., Edlund K., Rylander E., Wadell G., Wilander E. Nonradioisotopic detection and typing of human papillomaviruses by use of polymerase chain reaction and single-strand conformation polymorphism. Diagn Mol Pathol. 1996 Sep;5(3):206–213. doi: 10.1097/00019606-199609000-00010. [DOI] [PubMed] [Google Scholar]
  18. Zehbe I., Voglino G., Delius H., Wilander E., Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet. 1998 Oct 31;352(9138):1441–1442. doi: 10.1016/S0140-6736(05)61263-9. [DOI] [PubMed] [Google Scholar]
  19. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998 Feb 15;58(4):829–833. [PubMed] [Google Scholar]
  20. Zehbe I., Wilander E. Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology. J Pathol. 1997 Mar;181(3):270–275. doi: 10.1002/(SICI)1096-9896(199703)181:3<270::AID-PATH767>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  21. Zehbe I., Wilander E. Nonisotopic ELISA-based detection of human papillomavirus-amplified DNA. Mod Pathol. 1997 Mar;10(3):188–191. [PubMed] [Google Scholar]
  22. de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 Apr;76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057. [DOI] [PubMed] [Google Scholar]
  23. van Beurden M., ten Kate F. W., Tjong-A-Hung S. P., de Craen A. J., van der Vange N., Lammes F. B., ter Schegget J. Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol. 1998 Jan;17(1):12–16. doi: 10.1097/00004347-199801000-00003. [DOI] [PubMed] [Google Scholar]
  24. zur Hausen H. Viruses in human cancers. Science. 1991 Nov 22;254(5035):1167–1173. doi: 10.1126/science.1659743. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES